Company Filing History:
Years Active: 1983-1996
Title: Tibor Klupp: Innovator in Biopharmaceuticals
Introduction
Tibor Klupp is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of recombinant proteins and biologically active substances. With a total of 2 patents, Klupp's work has the potential to impact medical treatments significantly.
Latest Patents
Klupp's latest patents include a process for producing recombinant desulphatohirudin HV-1. This invention involves culturing microorganisms to synthesize a thrombin inhibitor that can be used to inhibit blood coagulation. The process utilizes E. coli, Saccharomyces, and Streptomyces species transformed with recombinant plasmids to biosynthesize the desired compound. His second patent relates to a process for preparing a biologically active substance isolated from normal white blood cells. This peptide has the capability to selectively inhibit the proliferation of both normal and leukemic myeloid cells.
Career Highlights
Throughout his career, Klupp has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Vegyeszeti Gyar Rt and Biogal Gyogyszergyar Rt. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.
Collaborations
Klupp has collaborated with notable colleagues such as Andras Balazs and Mihaly Sajgo. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Tibor Klupp's contributions to biopharmaceuticals through his patents and collaborations highlight his role as an innovator in the industry. His work continues to pave the way for advancements in medical treatments.